Gil Beyen

CEO at Montis Bioscience BV

Speaker

Gil Beyen has been a CEO of private and listed biotech companies for more than 25 years. Before joining Montis, he served as CEO and Board Director of ERYTECH Pharma, a dual-listed, late clinical stage biopharma company, based in France and Boston, MA.

Prior to that, Gil was CEO and Managing Director of TiGenix, a cell therapy company he co-founded and managed through IPO, first drug approval and commercial launch. He started his career as project engineer Environmental Biotechnologies and was a consultant and director at Arthur D. Little, an international management consulting firm, in Brussels, where he headed the life sciences practice.

Gil holds a MSc in Bioengineering from the University of Leuven (Belgium) and an M.B.A. from the University of Chicago (USA).